Home › Companies › Pharmaceuticals and biotechnology › United States
Is BIOMERICA INC (BMRA) stock halal?
Thresholds exceeded under all standards, and the strict view excludes it.
This verdict follows the median view, that of AAOIFI Standard No. 21. It is based on the financial statements for the fiscal year ended 05/31/2026.
The ratios
| Criterion | Measure | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0% of market capitalization | 30% | within threshold |
| Interest-bearing investments | 19.7% of market capitalization | 30% | within threshold |
| Impermissible income | 26.7% of revenue | 5% | threshold exceeded |
Standard: AAOIFI, Standard No. 21.
Margin to threshold and trend
| Item | Ratio (fiscal year end) | Threshold (AAOIFI, Standard No. 21) | Margin | Change since year end | Estimated ratio |
|---|---|---|---|---|---|
| Interest-bearing debt | 0% | 30% | 30% | not read | — |
| Interest-bearing investments | 19.7% | 30% | 10.3% | not read | — |
No quarterly financial statements after fiscal year end, or inconsistent reading: the change is not shown. "On watch" flags a permitted company whose estimated ratio reaches the threshold, or is within 5 points of the threshold and rising. This is neither a forecast nor advice.
The three views
- Median view, our reference : the company is excluded.
- Strictest view : the company is excluded, because it borrows or invests at interest.
- Most lenient view : the company is excluded.
Business activity
In Vitro & In Vivo Diagnostic Substances (SIC code 2835)
Financial statements read
Fiscal year ended 05/31/2026, in millions of dollars. Source: SEC EDGAR: annual reports of BIOMERICA INC.
What could not be verified
- Activity classified from the SEC sector code, without reading the annual report.
- Figures read automatically and not reviewed by a human.
Status history
Loading history…
In the same sector
- ELI LILLY & Co Questionable
- JOHNSON & JOHNSON Permitted
- AbbVie Inc. Permitted
- Merck & Co., Inc. Permitted
- AMGEN INC Prohibited
- GILEAD SCIENCES, INC. Permitted
- ABBOTT LABORATORIES Permitted
- PFIZER INC Questionable
Compliance comparison only: no opinion on the value of these securities.
General information: neither investment advice nor a fatwa. Verdict calculated by published rules, from financial statements read automatically and not reviewed by a human. Read the methodology